Publications by authors named "Shuji Harada"

Claim this Profile
C
Comparison of first-line immuno-oncology combinations with molecular targeted therapy in patients with advanced renal cell carcinoma undergoing hemodialysis: a real-world multicenter retrospective study.
Kosuke Ueda, Hiroki Kurata, Yoji Murakami, Akinori Minato, Masaki Shiota, Shuji Harada

Int J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of early kinetics of C‑reactive protein in patients with advanced urothelial carcinoma treated with pembrolizumab: Flare response and baseline levels predict oncological outcomes.
Ikko Tomisaki, Mirii Harada, Shigeru Sakano, Michikazu Terado, Ryoichi Hamasuna, Shuji Harada, Ken-Ichi Harada

Oncol Lett· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential impact of proton pump inhibitor on survival outcomes of patients with advanced urothelial carcinoma treated with chemotherapy versus pembrolizumab.
Ikko Tomisaki, Mirii Harada, Shigeru Sakano, Michikazu Terado, Ryoichi Hamasuna, Shuji Harada, Ken-Ichi Harada

Int J Urol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Body Mass Index and Outcomes in Patients With Urothelial Carcinoma Treated With Pembrolizumab.
Ikko Tomisaki, Mirii Harada, Shigeru Sakano, Michikazu Terado, Ryoichi Hamasuna, Shuji Harada, Ken-Ichi Harada

Anticancer Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and characterization of anisotropically expanded graphite oxide compounds derived from spherical graphite.
Wenwen Zhao, Gentoku Kido, Shuji Harada, Masashi Unno, Hideyuki Noguchi

J Colloid Interface Sci· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of estramustine phosphate according to risk classification of castration-resistant prostate cancer.
Akinori Minato, Naohiro Fujimoto, Tatsuhiko Kubo, Shuji Harada, Soichiro Akasaka

Med Oncol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of the phosphocholine linkage on sphingomyelin molecular properties and interactions with cholesterol; a study with phosphate oxygen modified sphingomyelin-analogues.
Anders Björkbom, Tetsuya Yamamoto, Satoshi Kaji, Shuji Harada, Shigeo Katsumura

Biochim Biophys Acta· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells.
Naohiro Fujimoto, Hiroshi Miyamoto, Atsushi Mizokami, Shuji Harada, Masayoshi Nomura

Cancer Invest· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Screening for prostate cancer in Yahata, Kitakyushu].
Naohiro Fujimoto, Shuji Harada, Hideki Sato, Soichiro Akasaka, Masayoshi Nomura

J UOEH· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple biopsies of normal-looking urothelium in patients with superficial bladder cancer: Are they necessary?
Naohiro Fujimoto, Shuji Harada, Michikazu Terado, Hideki Sato, Tetsuro Matsumoto

Int J Urol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis